AU772007B2 - Recombinant haemophilus influenzae adhesin proteins - Google Patents

Recombinant haemophilus influenzae adhesin proteins Download PDF

Info

Publication number
AU772007B2
AU772007B2 AU32680/00A AU3268000A AU772007B2 AU 772007 B2 AU772007 B2 AU 772007B2 AU 32680/00 A AU32680/00 A AU 32680/00A AU 3268000 A AU3268000 A AU 3268000A AU 772007 B2 AU772007 B2 AU 772007B2
Authority
AU
Australia
Prior art keywords
thr
ala
gly
lys
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU32680/00A
Other languages
English (en)
Other versions
AU3268000A (en
Inventor
Michel H. Klein
Sheena M Loosmore
Yan-Ping Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Publication of AU3268000A publication Critical patent/AU3268000A/en
Assigned to AVENTIS PASTEUR LIMITED reassignment AVENTIS PASTEUR LIMITED Change of Name of Applicant under S 104 Assignors: CONNAUGHT LABORATORIES LIMITED
Application granted granted Critical
Publication of AU772007B2 publication Critical patent/AU772007B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU32680/00A 1999-03-16 2000-03-16 Recombinant haemophilus influenzae adhesin proteins Ceased AU772007B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/268,347 US6335182B1 (en) 1999-03-16 1999-03-16 Recombinant Haemophilus influenzae adhesin proteins
US09/268347 1999-03-16
PCT/CA2000/000289 WO2000055191A2 (en) 1999-03-16 2000-03-16 Recombinant haemophilus influenzae adhesin proteins

Publications (2)

Publication Number Publication Date
AU3268000A AU3268000A (en) 2000-10-04
AU772007B2 true AU772007B2 (en) 2004-04-08

Family

ID=23022574

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32680/00A Ceased AU772007B2 (en) 1999-03-16 2000-03-16 Recombinant haemophilus influenzae adhesin proteins

Country Status (10)

Country Link
US (1) US6335182B1 (enExample)
EP (3) EP1903055A3 (enExample)
JP (3) JP2004529601A (enExample)
AT (1) ATE380823T1 (enExample)
AU (1) AU772007B2 (enExample)
CA (1) CA2364667A1 (enExample)
DE (1) DE60037413T2 (enExample)
MX (1) MXPA01009335A (enExample)
NZ (2) NZ514606A (enExample)
WO (1) WO2000055191A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785609B1 (en) 1999-03-16 2010-08-31 Sanofi Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
CA2379400A1 (en) * 1999-07-27 2001-02-01 Aventis Pasteur Limited Recombinant high molecular weight major outer membrane protein of moraxella
US7015033B1 (en) * 2000-05-25 2006-03-21 Aventis Pasteur Limited Co-expression of recombination proteins
US10279026B2 (en) 2012-04-26 2019-05-07 Glaxosmithkline Biologicals Sa Antigens and antigen combinations
MX374919B (es) 2012-04-26 2025-03-06 Glaxosmithkline Biologicals S A Star ANTÍGENOS Y COMBINACIONES DE ANTÍGENOS PARA USARSE PARA ELEVAR LA RESPUESTA INMUNE CONTRA Haemophilus influenzae.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030519A1 (en) * 1995-03-24 1996-10-03 Washington University Haemophilus adhesion proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE216826C (enExample)
US4258029A (en) 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
US4496538A (en) 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
DE3521994A1 (de) 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5194254A (en) 1986-05-06 1993-03-16 Connaught Laboratories Limited Enhancement of antigen immunogenicity
US5843463A (en) 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
JP3296817B2 (ja) 1991-04-02 2002-07-02 バイオテック・オーストラリア・ピーティーワイ・リミテッド 微粒子に適した経口配布系
AU686660B2 (en) * 1993-08-11 1998-02-12 Jenner Technologies Prostatic cancer vaccine
WO1995005853A1 (en) * 1993-08-26 1995-03-02 The Regents Of The University Of California Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
US6361779B1 (en) * 1993-11-08 2002-03-26 Aventis Pasteur Limited Transferrin receptor genes
US6764682B1 (en) 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
DE69534747T2 (de) 1994-07-19 2006-07-06 Wyeth Holdings Corp. Haemophilus influenzae (nt hi) lkp tip adhesin protein und nukleinsäure
US6335018B1 (en) 1995-05-01 2002-01-01 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
JP3203160B2 (ja) * 1995-08-09 2001-08-27 三菱電機株式会社 ボリューム・レンダリング装置及び方法
US6342232B1 (en) * 1999-03-03 2002-01-29 Aventis Pasteur Limited Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030519A1 (en) * 1995-03-24 1996-10-03 Washington University Haemophilus adhesion proteins
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins

Also Published As

Publication number Publication date
NZ514606A (en) 2004-05-28
NZ530979A (en) 2005-08-26
JP2004529601A (ja) 2004-09-30
EP2133359A3 (en) 2010-03-10
WO2000055191A2 (en) 2000-09-21
AU3268000A (en) 2000-10-04
MXPA01009335A (es) 2003-08-01
CA2364667A1 (en) 2000-09-21
WO2000055191A3 (en) 2001-08-02
US6335182B1 (en) 2002-01-01
DE60037413D1 (de) 2008-01-24
JP2011103893A (ja) 2011-06-02
EP1903055A3 (en) 2008-08-06
EP1180119A2 (en) 2002-02-20
EP1180119B1 (en) 2007-12-12
EP2133359A2 (en) 2009-12-16
DE60037413T2 (de) 2008-06-19
JP2008188018A (ja) 2008-08-21
ATE380823T1 (de) 2007-12-15
EP1903055A2 (en) 2008-03-26

Similar Documents

Publication Publication Date Title
CA2224127C (en) Flagellin gene, flac of campylobacter
AU739129B2 (en) Lactoferrin receptor genes of moraxella
US7666626B2 (en) Mutants of the P4 protein of nontypable Haemophilus influenzae with reduced enzymatic activity
US7192725B2 (en) Flagellin gene, flaC of Campylobacter
AU744733B2 (en) Neisseria lactoferrin binding protein
AU772007B2 (en) Recombinant haemophilus influenzae adhesin proteins
AU716506B2 (en) Transferrin receptor genes
US7785609B1 (en) Recombinant Haemophilus influenzae adhesin proteins
US6849447B2 (en) Protective recombinant Haemophilus influenzae high molecular weight proteins
EP1159001A2 (en) MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE)
AU765339B2 (en) Protective recombinant (haemophilus influenzae) high molecular weight proteins
NZ539569A (en) Recombinant haemophilus influenzae adhesin proteins
WO2002038593A1 (en) Haemophilus antigen
MXPA01003571A (en) Protective recombinant haemophilus influenzae

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 35, PAGE(S) 7527-7530 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 32680/00

TC Change of applicant's name (sec. 104)

Owner name: AVENTIS PASTEUR LIMITED

Free format text: FORMER NAME: CONNAUGHT LABORATORIES LIMITED

FGA Letters patent sealed or granted (standard patent)